Table 4: Cumulative postoperative complications 0-12 months postoperatively, among individuals alive at 12 months.
|
Postoperative complication, n (%), [95% C.I.] |
Study group |
Control group |
p-valuea) |
|
Endophthalmitis |
0 (0.00) [0.00, 0.08] |
0 (0.00) |
> 0.99 |
|
Postoperative CME - bilateral |
25 (0.54) [0.37, 0.80] 5 (0.11) |
18 (0.38) 6 (0.13) |
0.29 > 0.99 |
|
Persistent anterior uveitis - bilateral |
20 (0.44) [0.28, 0.67] 7 (0.15) |
18 (0.38) 6 (0.13) |
0.75 0.79 |
|
Retinal detachment - bilateral |
6 (0.13) [0.06, 0.28] 0 (0.00) |
5 (0.11) 1 (0.02) |
0.77 > 0.99 |
|
Corneal decompensation - bilateral |
1 (0.02) [0.004, 0.12] 0 (0.00) |
7 (0.15) 4 (0.08) |
0.07 0.13 |
|
Dry AMD progression to exudative AMD |
36 (0.78) [0.57, 1.08] |
28 (0.59) |
0.32 |
|
Malignant glaucoma |
0 (0.00) [0.00, 0.08] |
0 (0.00) |
> 0.99 |
|
|
|
|
|
|
Totally postoperative all complications, n (%) |
88 (1.92) |
76 (1.61) |
0.27 |
|
Without postoperative complications, n (%) |
4504 (98.08) |
4642 (98.39) |
0.27 |
|
Totally postoperative complications, AMD Excluded, n (%) |
52 (1.13) |
48 (1.02) |
0.62 |
|
Without postoperative complications, AMD Excluded, n (%) |
4540 (98.87) |
4670 (98.98) |
0.62 |
|
Patients died before the end of the follow up time, n (%) |
70 (2.96) |
68 (2.88) |
0.80 |
|
Operated eyes |
4592 |
4718 |
|
a) Fisher´s exact test, AMD: Age Related Macular Degeneration; CME: Cystic Macular Edema; n = number of patients, 95% C.I.= 95% confidence interval, *= statistically significant